5 trends tracked about this subject — the full history, oldest to newest below.
Bristol Myers Squibb is restructuring its research and development organization under Cristian Massacesi as chief research officer Robert Plenge prepares to exit.
The FDA is requiring all GLP-1 drug makers to add warnings about a possible increased risk of NAION, a rare eye condition that can cause sudden and permanent vision loss.
The pharmaceutical lobby group has launched a lawsuit against the Trump administration over most favored nation drug pricing policies.
A major setback for a promising cholesterol drug has cast doubt on a multibillion-dollar race to revolutionize heart health treatments.
AstraZeneca shares have declined following reports of potential $400 billion merger talks with Bristol Myers Squibb.